menu

ReachMD

Be part of the knowledge.
Register

We’re glad to see you’re enjoying ReachMD…
but how about a more personalized experience?

Register for free

Current Updates on Squamous Cell Cancer of the Head and Neck (SCCHN)

close
Current Updates on Squamous Cell Cancer of the Head and Neck (SCCHN)
Restart
Resume
Read full article
Choose a format
Media formats available:
Details
Comments
  • Overview

    Join Jan B. Vermorken, MD, PhD as he shares some of the exciting updates on Squamous Cell Cancer of the Head & Neck (SCCHN).

  • Learning Objectives

    At the completion of this module, participants will be better able to:

    1. Understand the latest advances in preimplantation genetic screening/ diagnosis that will optimize fetal outcomes in ART
    2. Utilize appropriate screening and diagnostic protocols according to evidence-based guidelines, and incorporate latest technologies into clinical decision-making 
  • Target Audience

    The target audience for this activity includes Reproductive Endocrinologists, Embryologists, and Certified RE and Embryology Lab Technicians.

  • Accreditation and Credit Designation Statements

    The Omnia-Prova Education Collaborative, Inc. is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.

    The Omnia-Prova Education Collaborative, Inc. designates this enduring material for a maximum of .5 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

    A statement of credit will be issued only upon receipt of a completed activity evaluation form and will be available for immediate download.

  • Commercial Support

    This activity is supported by an independent educational grant from Illumina, Inc.

    Original Release Date: 29 March 2015
    Expiration Date: 29 March 2016

  • Provider(s)/Educational Partner(s)

    Omnia Education has a core focus on women's health and the ways in which diseases and conditions impact the female patient. That unique focus has transformed the CME learning environment for healthcare professionals nationwide. We impact thousands of clinicians annually, many of whom return each year for clinical updates and connectivity with regional peers.

    Contact Information

    In case of technical needs, please contact: info@globalfertilityacademy.org

  • Disclosure of Conflicts of Interest

    FACULTY

    Robert E. Anderson, MD
    Medical Director
    Southern California Center for Reproductive Medicine
    Newport Beach, CA

    Financial Relationship Disclosure:
    Consulting fees: Serono 
    Speaker: Illumina, Inc.

    Brian Kaplan, MD
    Fertility Center of Illinois
    Chicago, IL

    Financial Relationship Disclosure:
    Consulting fees: Actavis, Ferring, Good Start Genetics, Serono

    MODERATOR

    Michael J. Tucker, PhD, HCLD, FI Biol
    IVF Laboratory Director
    Shady Grove Fertility RSC
    Rockville, MD

    Financial Relationship Disclosure:
    No relationships reported

    REVIEWERS/PLANNERS/AUTHORS

    Barry A. Fiedel, PhD
    Financial Relationship Disclosure:
    No relationships reported

    Amanda Hilferty
    Financial Relationship Disclosure:
    No relationships reported

    Sean T. Saunders, CCMEP
    Financial Relationship Disclosure:
    No relationships reported

    Robert Schneider
    Financial Relationship Disclosure:
    No relationships reported

    Lee Philip Shulman, MD, FACOG, FACMG
    Financial Relationship Disclosure:
    Consultant: Actavis, Bayer, Merck, Natera, Quest, Sequenom, Inc.
    Speaker: Actavis, Bayer, Merck, Pfizer, Roche

Facebook Comments

Recommended
Details
Comments
  • Overview

    Join Jan B. Vermorken, MD, PhD as he shares some of the exciting updates on Squamous Cell Cancer of the Head & Neck (SCCHN).

  • Learning Objectives

    At the completion of this module, participants will be better able to:

    1. Understand the latest advances in preimplantation genetic screening/ diagnosis that will optimize fetal outcomes in ART
    2. Utilize appropriate screening and diagnostic protocols according to evidence-based guidelines, and incorporate latest technologies into clinical decision-making 
  • Target Audience

    The target audience for this activity includes Reproductive Endocrinologists, Embryologists, and Certified RE and Embryology Lab Technicians.

  • Accreditation and Credit Designation Statements

    The Omnia-Prova Education Collaborative, Inc. is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.

    The Omnia-Prova Education Collaborative, Inc. designates this enduring material for a maximum of .5 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

    A statement of credit will be issued only upon receipt of a completed activity evaluation form and will be available for immediate download.

  • Commercial Support

    This activity is supported by an independent educational grant from Illumina, Inc.

    Original Release Date: 29 March 2015
    Expiration Date: 29 March 2016

  • Provider(s)/Educational Partner(s)

    Omnia Education has a core focus on women's health and the ways in which diseases and conditions impact the female patient. That unique focus has transformed the CME learning environment for healthcare professionals nationwide. We impact thousands of clinicians annually, many of whom return each year for clinical updates and connectivity with regional peers.

    Contact Information

    In case of technical needs, please contact: info@globalfertilityacademy.org

  • Disclosure of Conflicts of Interest

    FACULTY

    Robert E. Anderson, MD
    Medical Director
    Southern California Center for Reproductive Medicine
    Newport Beach, CA

    Financial Relationship Disclosure:
    Consulting fees: Serono 
    Speaker: Illumina, Inc.

    Brian Kaplan, MD
    Fertility Center of Illinois
    Chicago, IL

    Financial Relationship Disclosure:
    Consulting fees: Actavis, Ferring, Good Start Genetics, Serono

    MODERATOR

    Michael J. Tucker, PhD, HCLD, FI Biol
    IVF Laboratory Director
    Shady Grove Fertility RSC
    Rockville, MD

    Financial Relationship Disclosure:
    No relationships reported

    REVIEWERS/PLANNERS/AUTHORS

    Barry A. Fiedel, PhD
    Financial Relationship Disclosure:
    No relationships reported

    Amanda Hilferty
    Financial Relationship Disclosure:
    No relationships reported

    Sean T. Saunders, CCMEP
    Financial Relationship Disclosure:
    No relationships reported

    Robert Schneider
    Financial Relationship Disclosure:
    No relationships reported

    Lee Philip Shulman, MD, FACOG, FACMG
    Financial Relationship Disclosure:
    Consultant: Actavis, Bayer, Merck, Natera, Quest, Sequenom, Inc.
    Speaker: Actavis, Bayer, Merck, Pfizer, Roche

Facebook Comments

Programs 3/3/21